I endeavour to integrate and optimise the pre-clinical development and science-led clinical application of novel therapies and novel therapeutic combinations, including first into man (phase I) and associated studies.  My research goal is to identify successful, new therapeutic approaches for the treatment of patients with cancer with much of my effort now focussing on pancreatic cancer.

An overview of pancreatic ductal adenocarcinoma and current drug treatment (presentation from the Lectures in Cancer Biology talk given at the Cancer Research UK Cambridge Institute in April 2016)